EICHOR
● Active Not Recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Condition: Atrial Fibrillation · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (1052)
| Advanced Cardiovascular, LLC | Alexander City, Alabama, United States | — |
| Ascension St. Vincent's Health System | Birmingham, Alabama, United States | — |
| SEC Clinical Research | Dothan, Alabama, United States | — |
| HH Heart Center and Heart Center | Huntsville, Alabama, United States | — |
| CB Flock Research Corporation | Mobile, Alabama, United States | — |
| Mercy Gilbert Medical Center | Gilbert, Arizona, United States | — |
| Valleywise Health Medical Center | Phoenix, Arizona, United States | — |
| Arizona Arrhythmia Research Center | Phoenix, Arizona, United States | — |
| Arizona Heart Hospital | Phoenix, Arizona, United States | — |
| HonorHealth Neurology 1 | Scottsdale, Arizona, United States | — |
| HonorHealth Neurology | Scottsdale, Arizona, United States | — |
| Arkansas Heart Hospital | Little Rock, Arkansas, United States | — |
+ 1040 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05757869